NERV
Income statement / Annual
Last year (2023), Minerva Neurosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Minerva Neurosciences, Inc.'s net income was -$30.01 M.
See Minerva Neurosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$41.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$30,982.00 |
$8,513.00 |
$101,786.00 |
$0.00 |
$161,507.00 |
$17,467.00 |
$11,094.00 |
$16,530.00 |
$17,276.00 |
$0.00 |
Gross Profit |
-$30,982.00 |
-$8,513.00 |
-$101,786.00 |
$41.18 M |
-$161,507.00 |
-$17,467.00 |
-$11,094.00 |
-$16,530.00 |
-$17,276.00 |
$0.00 |
Gross Profit Ratio |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$12.71 M
|
$14.65 M
|
$32.04 M
|
$22.04 M
|
$58.12 M
|
$34.89 M
|
$30.26 M
|
$20.44 M
|
$18.53 M
|
$42.91 M
|
General & Administrative
Expenses |
$10.41 B
|
$10.58 M
|
$13.33 M
|
$17.29 M
|
$17.74 M
|
$16.84 M
|
$10.91 M
|
$9.75 M
|
$7.58 M
|
$11.96 M
|
Selling & Marketing
Expenses |
-$10.40 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$10.38 M
|
$10.58 M
|
$13.33 M
|
$17.29 M
|
$17.74 M
|
$16.84 M
|
$10.91 M
|
$9.75 M
|
$7.58 M
|
$11.96 M
|
Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$23.09 M |
$25.23 M |
$45.37 M |
$39.33 M |
$75.86 M |
$51.73 M |
$41.17 M |
$30.19 M |
$26.11 M |
$54.87 M |
Cost And Expenses |
$23.12 M |
$25.23 M |
$45.37 M |
$39.33 M |
$75.86 M |
$51.73 M |
$41.17 M |
$30.19 M |
$26.11 M |
$54.87 M |
Interest Income |
$1.44 M |
$556,946.00 |
$16,516.00 |
$161,207.00 |
$1.46 M |
$1.67 M |
$941,833.00 |
$198,000.00 |
$96,910.00 |
$0.00 |
Interest Expense |
$8.28 M |
$7.41 M |
$6.33 M |
$0.00 |
$0.00 |
$110,448.00 |
$614,264.00 |
$1.03 M |
$1.05 M |
$2.05 M |
Depreciation &
Amortization |
$30,982.00
|
$8,513.00
|
$101,786.00
|
$176,177.00
|
$161,507.00
|
$17,467.00
|
$11,094.00
|
$16,530.00
|
$17,276.00
|
$33,869.00
|
EBITDA |
-$21.69 M
|
-$24.69 M
|
-$51.61 M
|
$1.93 M
|
-$74.28 M
|
-$50.04 M
|
-$40.27 M
|
-$30.00 M
|
-$26.01 M
|
-$54.81 M
|
EBITDA Ratio |
0 |
0 |
0 |
0.05 |
0 |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
0
|
0
|
0
|
0.04
|
0
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
-$6.89 M
|
-$6.88 M
|
-$6.34 M
|
$94,024.00
|
-$17.57 M
|
$1.56 M
|
$270,682.00
|
-$854,676.00
|
-$972,013.00
|
-$2.03 M
|
Income Before Tax |
-$30.01 M |
-$32.11 M |
-$51.71 M |
$1.94 M |
-$74.44 M |
-$50.17 M |
-$40.90 M |
-$31.05 M |
-$27.08 M |
-$56.90 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0.05
|
0
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
-$2.00 |
$6.88 M |
-$1.80 M |
-$94,024.00 |
-$2.25 M |
$1.67 M |
-$9.38 M |
$1.03 M |
$1.05 M |
$2.05 M |
Net Income |
-$30.01 M |
-$38.99 M |
-$49.91 M |
$1.94 M |
-$72.18 M |
-$50.17 M |
-$31.52 M |
-$31.05 M |
-$27.08 M |
-$56.90 M |
Net Income Ratio |
0 |
0 |
0 |
0.05 |
0 |
0 |
0 |
0 |
0 |
0 |
EPS |
-4.61 |
-7.3 |
-9.35 |
0.38 |
-14.8 |
-10.35 |
-6.65 |
-7.88 |
-9.25 |
-35.77 |
EPS Diluted |
-4.61 |
-7.3 |
-9.35 |
0.38 |
-14.8 |
-10.35 |
-6.65 |
-7.88 |
-9.25 |
-35.77 |
Weighted Average Shares
Out |
$6.51 M
|
$5.34 M
|
$5.34 M
|
$5.10 M
|
$4.88 M
|
$4.85 M
|
$4.74 M
|
$3.94 M
|
$2.93 M
|
$1.59 M
|
Weighted Average Shares
Out Diluted |
$6.51 M
|
$5.34 M
|
$5.34 M
|
$5.11 M
|
$4.88 M
|
$4.85 M
|
$4.74 M
|
$3.94 M
|
$2.93 M
|
$1.59 M
|
Link |
|
|
|
|
|
|
|
|
|
|